Company to Divest Late Stage Operations, Signs Agreement to Sell Phase II-IV Operations to INC Research TORONTO, June 1 /PRNewswire-FirstCall/ - MDS Inc.

INC Research (R), Inc., a therapeutically-focused contract research organization (CRO) with a process for delivering reliable results, today announced the addition of Dr. Renee Simar as the company's principle pediatric strategist. In this role, Dr.

INC Research (R), Inc., a therapeutically-focused contract research organization (CRO) with a process for delivering reliable results, today announced that David Subich, MD has been named the senior director, Clinical Operations for Metabolic & Endocrine Diseases.